If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 10 of 11
A Randomized Controlled Trial of Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Objective
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Protocol No
PULM-RUSH-POSTEXTUBATION
An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Objective
Extension Study of Inhaled Treprostinil in Subjects With IPF
Protocol No
PULM-UNITED-TETON-OLE
Categories
RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Objective
RECOVER-SLEEP: Platform Protocol
Protocol No
PULM-DUKE-RECOVER-SLEEP
Categories
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Objective
Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis
Protocol No
PULM-UNITED-TETON-PPF
Categories
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema: The CONVERT II Trial
Objective
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema
Protocol No
PULM-PULMONX-CONVERT-II
Categories
A Multicenter Randomized Controlled Trial to Establish the Impact of MeMed BV® on Management of Patients with Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) (JUPITER TRIAL)
Objective
Management of LRTI in the ED and UCC - JUPITER
Protocol No
EM-MEMED-JUPITER
Categories
A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg Administered Once Daily for up to 76 Weeks in Patients With Bronchiectasis (The AIRTIVITY Study)
Objective
The AIRTIVITY Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Protocol No
PULM-BOEHRINGER-AIRTIVITY
Categories
Study to Evaluate New Diagnostics for Pulmonary Microbes in People with CF (SEND-CF)
Objective
New Diagnostics for Pulmonary Microbes in People with CF
Protocol No
PULM-CFF-SEND-CF
Categories
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Objective
Bronchoscopic Release of Air Trapped in Hyperinflated Emphysematous Lung
Protocol No
PULM-APREO-BREATHE-3
Categories
Standardizing Treatments for Pulmonary Exacerbations: A Platform for Evaluating Treatment Decisions to Improve Outcomes (STOP360) Aminoglycoside Study (AG Study)
Objective
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study (STOP360AG)
Protocol No
PULM-CFF-STOP360AG
Categories